(Circulation. 2007;115:2091-2093.)
© 2007 American Heart Association, Inc.
Editorial |
From Struttura Complessa di Cardiologia, Unità di Ricerca ClinicaCardiologia Preventiva, Ospedale S. Maria della Misericordia, Perugia, Italy.
Correspondence to Paolo Verdecchia, MD, FAHA, FACC, Struttura Complessa di Cardiologia, Unità di Ricerca ClinicaCardiologia Preventiva, Ospedale S. Maria della Misericordia, Piazzale G. Menghini, 06132 Perugia, Italy. E-mail verdec@tin.it
Key Words: Editorials blood pressure circadian rhythm diagnosis hypertension prevention prognosis
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
|
Article p 2145
Three aspects of available investigations deserve special mention. First, the prognostic value of ABP has been examined not only in subjects with clinical diagnosis of hypertension but also in the general population and in a variety of settings, including diabetes mellitus, renal failure, and cerebrovascular disease. Second, subjects could be untreated or treated at the time of ABP monitoring. This point may raise concerns, because drug treatment could exert unpredictable effects on 24-hour ABP profile and, consequently, interpretation and applicability of results. Third, although a continuous relation
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |